Tag
China pharmaceutical industry
![Are China’s Healthcare and Biopharma Sectors Really Open for Investment? Are China’s Healthcare and Biopharma Sectors Really Open for Investment?](https://thediplomat.com/wp-content/uploads/2023/09/sizes/thumbnail/thediplomat_2023-09-08-183540.jpg)
Are China’s Healthcare and Biopharma Sectors Really Open for Investment?
By Patrick Beyrer
To attract foreign investment, the Chinese healthcare and biopharma sectors are more open for business than ever – or at least they claim to be. But challenges exist beneath the surface.
![COVID-19 Is Reshaping Global Pharmaceutical Competition – to Asia’s Benefit COVID-19 Is Reshaping Global Pharmaceutical Competition – to Asia’s Benefit](https://thediplomat.com/wp-content/uploads/2021/10/sizes/thumbnail/thediplomat_2021-10-08-18.jpg)
COVID-19 Is Reshaping Global Pharmaceutical Competition – to Asia’s Benefit
By Hannah Elyse Sworn
The valuable experience gained by Asian companies during the pandemic could upset the West’s monopoly in high-value drugs more generally, with implications for global access to medicines.
![As China Rolled Out Its COVID-19 Shots, Victims of Earlier Vaccine Scandals Vanished As China Rolled Out Its COVID-19 Shots, Victims of Earlier Vaccine Scandals Vanished](https://thediplomat.com/wp-content/uploads/2021/05/sizes/thumbnail/thediplomat-2021-05-13-1.jpg)
As China Rolled Out Its COVID-19 Shots, Victims of Earlier Vaccine Scandals Vanished
By Renee Xia
China’s habit of disappearing and censoring critics is not the way to win trust in its vaccine industry.
![The Politics Behind China’s COVID-19 Vaccine Choices The Politics Behind China’s COVID-19 Vaccine Choices](https://thediplomat.com/wp-content/uploads/2021/02/sizes/thumbnail/thediplomat-2021-02-19-6.jpg)
The Politics Behind China’s COVID-19 Vaccine Choices
By Bonnie Girard
China is keeping its vaccination campaign homegrown -- despite some reservations from the public.
![China Prepares for Big Pharma China Prepares for Big Pharma](https://thediplomat.com/wp-content/uploads/2018/03/sizes/thumbnail/thediplomat-rawpixel-com-550991-unsplash.jpg)
China Prepares for Big Pharma
By Zachary Torrey
Pharmaceuticals is a target industry under the “Made in China 2025” plan.
![Why China Could be a Game Changer for Global Health Why China Could be a Game Changer for Global Health](https://thediplomat.com/wp-content/uploads/2017/04/sizes/thumbnail/thediplomat.com-1200px-chinese_army_active_in_sierra_leone_during_the_ebola_outbreak.jpg)
Why China Could be a Game Changer for Global Health
By Charlotte Röhren
With its growing international integration, China is becoming a major actor in global health issues.
![Chinese Consumers Will Change the Global Economy Chinese Consumers Will Change the Global Economy](https://thediplomat.com/wp-content/uploads/2017/04/sizes/thumbnail/thediplomat_2017-04-06_13-56-07.jpg)
Chinese Consumers Will Change the Global Economy
By Matthias Lomas
As China's massive population begins to spend more, the world will take notice.
![China Celebrates Its First Nobel Prize in the Sciences China Celebrates Its First Nobel Prize in the Sciences](https://thediplomat.com/wp-content/uploads/2015/10/sizes/thumbnail/thediplomat_2015-10-05_20-43-00.jpg)
China Celebrates Its First Nobel Prize in the Sciences
By Shannon Tiezzi
The winner, Tu Youyou, fused herbal research and biochemistry to develop a new anti-malaria drug.
![Ali Health: A Revolution for China’s Healthcare Industry? Ali Health: A Revolution for China’s Healthcare Industry?](https://thediplomat.com/wp-content/uploads/2015/05/sizes/thumbnail/thediplomat_2015-05-04_11-12-13.jpg)
Ali Health: A Revolution for China’s Healthcare Industry?
By Ariella Rotenberg and Peng Di
Led by Alibaba, private-sector players are threatening a major shakeup of China’s healthcare sector.
![Has China Found the Cure for Ebola? Has China Found the Cure for Ebola?](https://thediplomat.com/wp-content/uploads/2014/10/sizes/thumbnail/thediplomat_2014-10-15_20-45-47.jpg)
Has China Found the Cure for Ebola?
By Shannon Tiezzi
A Chinese pharmaceutical company is seeking to fast-track approval of an experimental cure for Ebola.
Page 1 of 1